Accessibility Menu
Biome Australia logo

Biome Australia(ASX) BIO

Market CapA$67.26MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)+138%
5 YearN/A
1 Year-43%
1 Month+17%
A$0.29
-3.39%
-0.01Today
Biome Australia last closing stock price
MetricPriceDate
Last closeAUD 0.302026-08-13
Biome Australia stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+3.51%AUD 0.292026-08-06
1 month+17.06%AUD 0.252026-07-14
3 month+5.36%AUD 0.282026-05-15
Year to date-29.76%AUD 0.422025-12-31
1 year-43.27%AUD 0.522025-08-13
3 year+96.67%AUD 0.152023-08-14
Since inception+137.5%AUD 0.122021-11-30

Biome Australia Financials at a Glance

Market Cap

A$67.26MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$37.81M

Net Income (TTM)

A$1.25M

EPS (TTM)

A$0.00

P/E Ratio

68.60

Dividend

A$0.00

Beta (Volatility)

-0.02 (Low)

Price

A$0.29

Volume

90,232

Open

A$0.29

Previous Close

A$0.30

Daily Range

A$0.29 - A$0.29

52-Week Range

A$0.20 - A$0.57

Estimated Earnings Date

Sep 1, 2026

BIO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Biome Australia

Biome Australia Limited is a biotechnology company focused on developing, commercializing, and distributing live biotherapeutic and complementary health products. Founded in 2018 and headquartered in Cremorne, Australia, the company offers a range of health products through its Activated Probiotics, Activated Nutrients, and Activated X Performance brands.

Products and Services
  • Live biotherapeutics under the Activated Probiotics brand
  • Organic nutritional supplements branded as Activated Nutrients
  • Athletic performance and recovery products named Activated X Performance
Growth Outlook
  • Recent quarterly revenue reached AUD 12.4 million, a significant increase
  • Strong gross profit margin of 60% indicates effective cost management
  • Expansion into new markets expected to drive future revenue growth
Financial Highlights
  • Trailing twelve months (TTM) revenue of AUD 36.5 million reflects robust sales performance
  • Net income for the latest quarter was AUD 1.2 million, showcasing profitability
  • Current ratio of 2.00 indicates strong liquidity position
Biome Australia Limited is positioned in a growing sector, with a focus on health and wellness products that cater to increasing consumer demand for natural and effective health solutions. The company's diverse product offerings and strategic market expansion plans are expected to contribute positively to its financial performance in the coming years. Recent financial results demonstrate a solid revenue trajectory and profitability, making it an intriguing option for investors interested in the biotechnology space.
AI Generated • Jul 26, 2026

Industry

Personal Products

CEO

Blair William Brabin Vega Norfolk

Headquarters

Collingwood, VIC 3066, AU

BIO Financials

Key Financial Metrics (TTM)

Gross Margin

60.50%

Operating Margin

3.33%

Net Income Margin

4.36%

Return on Equity

17.85%

Return on Capital

3.59%

Return on Assets

7.78%

Earnings Yield

1.46%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$67.26MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

228.00M

Volume

90.23K

Avg. Volume

322.46K

Financials (TTM)

Gross Profit

A$22.86M

Operating Income

A$627.57K

EBITDA

A$1.02M

Operating Cash Flow

-A$243.15K

Capital Expenditure

-A$89.92K

Free Cash Flow

-A$333.07K

Cash & ST Invst.

A$3.36M

Total Debt

A$2.43M

Biome Australia Performance Analysis

Biome Australia annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30AUD 4,122,425N/A
20232023-06-30AUD 7,235,61175.5%
20242024-06-30AUD 13,008,89779.8%
20252025-06-30AUD 18,417,18841.6%
Biome Australia sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-3016.3%
Q22024-12-3126.8%
Q42025-06-307.8%
Q22025-12-3129.8%
Biome Australia annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30AUD -0.02N/A
20232023-06-30AUD -0.02-32.6%
20242024-06-30AUD -0.01-47.7%
20252025-06-30AUD 0.00N/A
Biome Australia sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-3090.7%
Q22024-12-31371.4%
Q42025-06-30-152.6%
Q22025-12-31620.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

A$12.40M

+106.1%

Gross Profit

A$7.43M

+112.5%

Gross Margin

59.96%

N/A

Market Cap

A$67.26MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$2.24M

N/A

Employees

30

N/A

Net Income

A$1.18M

+177.1%

EBITDA

A$823.76K

+150.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

A$3.36M

+65.8%

Total Debt

A$2.43M

+67.6%

Accounts Receivable

A$3.31M

+45.2%

Inventory

A$3.89M

+87.0%

Long Term Debt

A$694.89K

+131.9%

Short Term Debt

A$1.74M

+50.8%

Return on Assets

7.78%

N/A

Return on Invested Capital

10.71%

N/A

Free Cash Flow

A$2.04M

+406.5%

Operating Cash Flow

A$2.09M

+418.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ALA.AXArovella Therapeutics Limited
A$0.06+1.67%
ATX.AXAmplia Therapeutics Limited
A$0.15-0.00%
IMU.AXImugene Limited
A$0.08-1.20%
EZZ.AXEZZ Life Science Holdings Limited
A$0.47+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$8.91-0.09%
SMCISuper Micro Computer
$39.16+0.04%
SPCXSpace Exploration Technologies
$141.29-0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.64+0.07%

Questions About BIO

What is the current price of Biome Australia?

Biome Australia is trading at A$0.29 per share.

What is the 52-week range for Biome Australia?

Over the past 52 weeks, Biome Australia has traded between A$0.20 and A$0.57.

How much debt does Biome Australia have?

As of the most recent reporting period, Biome Australia reported total debt of A$3.07M.

How much cash does Biome Australia have on hand?

Biome Australia reported A$2.75M in cash and cash equivalents in its most recent financial results.

What is Biome Australia’s dividend yield?

Biome Australia does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.